Summit Therapeutics (SMMT) Non-Current Assets (2014 - 2026)
Summit Therapeutics' Non-Current Assets was $32.12 million in Q3 2026, up 110.5% from $15.26 million a year earlier and up 1.6% from the prior quarter.
Summit Therapeutics (SMMT) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Summit Therapeutics came in at $30.88 million, up 161.5% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $11.81 million in FY2024 (-10.8%), $13.24 million in FY2023 (+77.5%), $7.46 million in FY2022 (-53.6%) and $16.06 million in FY2021 (+8.4%).
- The Q3 2026 figure marks the highest quarterly Non-Current Assets in data going back to Q4 2019.
- Compared with a year earlier, Non-Current Assets has increased for six straight quarters, with growth averaging 68.2% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2025 (growth of 161.5%); the worst was Q1 2023 (a decline of 59.7%).
- Per Business Quant data, SMMT's Non-Current Assets in the three quarters before Q3 2026 was $31.61 million (Q2 2026), $31.26 million (Q1 2026) and $30.88 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - | 32.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 32.12 Mn |
| Jun 30, 2026 | 31.61 Mn |
| Mar 31, 2026 | 31.26 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Sep 30, 2025 | 15.26 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Mar 31, 2025 | 13.07 Mn |
| Dec 31, 2024 | 11.81 Mn |
| Sep 30, 2024 | 12.56 Mn |
| Jun 30, 2024 | 13.06 Mn |
| Mar 31, 2024 | 13.52 Mn |
| Dec 31, 2023 | 13.24 Mn |
| Sep 30, 2023 | 13.53 Mn |
| Jun 30, 2023 | 9.87 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 7.46 Mn |
| Sep 30, 2022 | 18.21 Mn |
| Jun 30, 2022 | 16.32 Mn |
| Mar 31, 2022 | 17.04 Mn |
| Dec 31, 2021 | 16.06 Mn |
Summit Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SMMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();